Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-02-05

FDA Approved: INDAPAMIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for indapamide from Actavis Pharma, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indapamide (Indapamide)

Snippet

SUPPL AP for INDAPAMIDE (INDAPAMIDE)